$NVAX Trending Back Down to the Buy Zone

NVAX has started distributing millions of COVID-19 vaccine shots. However, NVAX is trending back down towards the buy zone. I think that this will present a great second chance buy opportunity after NVAX's recent rally to $8. The markets have been affected by the new Israel Palestine conflict. Other key events this week are September PPI inflation data and Fed meeting minutes on Wednesday October 11. I think the markets are likely to have some sideways price action on Tuesday in anticipation of the new inflation and fed data.
Chart PatternsTechnical IndicatorsnovavaxNVAXnvaxlongnvaxshortTrend Analysis

Aussi sur:

Publications connexes

Clause de non-responsabilité